Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1995-05-23
1997-02-11
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
4241921, 4242381, 424 932, 424832, 4351723, 435 691, 435 697, 435194, 4352523, 43525231, 43525232, 43525233, 43525411, 4353201, A61K 3905, A61K 4800, C12N 1531
Patent
active
056018274
ABSTRACT:
A DNA encoding an immunologically cross-reactive form of diphtheria toxin Fragment A, wherein the codons corresponding to Val-147 and Glu-148 of naturally-occurring diphtheria toxin are deleted from the DNA.
REFERENCES:
patent: 4709017 (1987-11-01), Collier et al.
patent: 4950740 (1990-08-01), Greenfield et al.
patent: 5149532 (1992-09-01), Brunell
Cieplak et al (1988) Proc. Nat. Acad Sci, USA 85 4667-4671.
Barbieri, et al., Expression of a Mutant, Full-Length Form of Diphtheria Toxin in Escherichia coli, Infection and Immunity, 55:1647-1651, 1987.
Fisher, et al., Construction and Expression of Plasmids Containing Mutated Diphtheria Toxin A-Chain-Coding Sequences, Infection and Immunity, 59:3562-3565, 1991.
Giannini, et al., The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197, Nucleic Acids Research, 12:4063-4069, 1984.
Greenfield, et al., Mutations in Diphtheria Toxin Separate Binding from Entry and Amplify Immunotoxin Selectivity, Science, 238:536-539, 1987.
Greenfield, et al., Nucleotide sequence of the structural gene for diphtheria toxin carried by corynebacteriophage.beta., PNAS, 80:6853-6857, 1983.
Locht, et al., Identification of amino acid residues essential for the enzymatic activities of pertussis toxin, PNAS, 86:3075-3079, 1989.
Tweten, et al., Diphtheria Toxin, Effect of Substituting Aspartic Acid For Glutamic Acid 148 on Adp-Ribosyltyransferase Activity, The J. of Biol. Chem., 260:10392-10394, 1985.
Maxwell, et al., Cloning, Sequence Determination, and Expression in Transfected Cells of the Coding Sequence of the tox 176 Attenuated Diphtheria Toxin A Chain, Mol. and Cell. Bio., 7:1576-1579, 1987.
Tang, et al., Genetic immunization is a simple method for eliciting an immune response, Nature, 356:152-154 1973.
Uchida, et al., Mutation in the Structural Gene for Diphtheria Toxin carried by Temperate Phage .beta., Nature New Biology, 33:8-11, 1971.
Uchida, et al., Diphtheria Toxin and Related Proteins, The J. of Biol. Chem., 248:3838-3844, 1973.
Ward, diphtheria toxin: a novel cytocidal enzyme, Trends Biochem, 12:28-30, 1987.
Wilson, et al., Active-Site of Diphtheria Toxin: Effects of Replacing Glutamic Acid-148 with Aspartic Acid, Glutamine, or Serine, Biochem., 29:8643-8651, 1990.
Choe, et al., The crystal structure of diphtheria toxin, Nature, 357:216-222, 1992.
Luka cet al (1988) Infect. Immun. 56: 3095-3098.
Collier R. John
Killeen Kevin
Mekalanos John
Bugaisky Gabriele E.
President and Fellows of Harvard College
Wax Robert A.
LandOfFree
Diphtheria toxin vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diphtheria toxin vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diphtheria toxin vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-339795